Overview

A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Status:
Not yet recruiting

Trial end date:
2024-04-14

Target enrollment:

Participant gender:

Summary

The main trial objective, is to ascertain whether the transport activity, given by the maximum concentration (Cmax) and the area under the curve (AUC0-24) values for the different components in the transporter cocktail are similar or different in F4 liver cirrhosis patients on standard therapy compared to healthy subjects.

Phase:

N/A

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Digoxin
Furosemide
Metformin
Rosuvastatin Calcium